Effects of honokiol on sepsis-induced acute kidney injury in an experimental model of sepsis in rats

Inflammation. 2014 Aug;37(4):1191-9. doi: 10.1007/s10753-014-9845-x.

Abstract

Acute kidney injury (AKI) is a severe complication of sepsis, which largely contributes to the high mortality rate of sepsis. Honokiol, a natural product isolated from Magnolia officinalis (Houpo), has been shown to exhibit anti-inflammatory and antioxidant properties. Here, we investigated the effects of honokiol on sepsis-associated AKI in rats subjected to cecal ligation and puncture (CLP). We found that the administration of honokiol improved the survival of septic rats. Periodic acid-Schiff stain revealed that the morphological changes of kidney tissues in CLP rats were restored after honokiol treatment. Furthermore, honokiol reduced CLP-induced oxidative stress and inflammatory cytokine production. The levels of nitric oxide (NO) and inducible NO synthetase (iNOS) were attenuated by honokiol in septic rats. Finally, honokiol inhibited CLP-induced activation of NF-κB signaling in CLP rats. Our findings suggest that honokiol might be used as a potential therapeutic agent for complications of sepsis, especially for sepsis-induced AKI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / drug therapy*
  • Animals
  • Antioxidants / pharmacology
  • Biphenyl Compounds / pharmacology*
  • Cytokines / metabolism
  • Disease Models, Animal
  • Inflammation
  • Kidney / pathology
  • Lignans / pharmacology*
  • Male
  • NF-kappa B / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Oxidative Stress
  • Rats
  • Rats, Sprague-Dawley
  • Sepsis / complications*
  • Sepsis / drug therapy*
  • Signal Transduction

Substances

  • Antioxidants
  • Biphenyl Compounds
  • Cytokines
  • Lignans
  • NF-kappa B
  • honokiol
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat